Answers are grounded in this paper and cite their sources.
The new nomenclature of MASLD and SLD is more applicable to identifying significant fibrosis than NAFLD. Patients with three or more cardiometabolic risk factors are at higher risk of fibrosis.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: